2.05 USD
+1.61 (+368.57%)
1.55 USD
-0.5 (-24.39%)
Taking everything into account, LPTX scores 2 out of 10 in our fundamental rating. LPTX was compared to 525 industry peers in the Biotechnology industry. The financial health of LPTX is average, but there are quite some concerns on its profitability. LPTX does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- LPTX had negative earnings in the past year.
- LPTX had a negative operating cash flow in the past year.
- LPTX had negative earnings in each of the past 5 years.
- In the past 5 years LPTX always reported negative operating cash flow.
1.2 Ratios
- The Return On Assets of LPTX (-327.74%) is worse than 94.21% of its industry peers.
- The Return On Equity of LPTX (-1148.94%) is worse than 81.12% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -327.74% | ||
| ROE | -1148.94% | ||
| ROIC | N/A |
ROA(3y)-109.13%
ROA(5y)-86.19%
ROE(3y)-140.51%
ROE(5y)-107.95%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for LPTX so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- Compared to 1 year ago, LPTX has more shares outstanding
- LPTX has more shares outstanding than it did 5 years ago.
- There is no outstanding debt for LPTX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- LPTX has an Altman-Z score of -39.98. This is a bad value and indicates that LPTX is not financially healthy and even has some risk of bankruptcy.
- The Altman-Z score of LPTX (-39.98) is worse than 91.78% of its industry peers.
- There is no outstanding debt for LPTX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -39.98 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- LPTX has a Current Ratio of 1.34. This is a normal value and indicates that LPTX is financially healthy and should not expect problems in meeting its short term obligations.
- LPTX has a worse Current ratio (1.34) than 82.99% of its industry peers.
- A Quick Ratio of 1.34 indicates that LPTX should not have too much problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 1.34, LPTX is doing worse than 82.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.34 | ||
| Quick Ratio | 1.34 |
3. Growth
3.1 Past
- LPTX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.79%, which is quite impressive.
EPS 1Y (TTM)36.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.82%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- Based on estimates for the next years, LPTX will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.37% on average per year.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y38.47%
EPS Next 2Y30.62%
EPS Next 3Y19.23%
EPS Next 5Y13.37%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for LPTX. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LPTX. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as LPTX's earnings are expected to grow with 19.23% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.62%
EPS Next 3Y19.23%
5. Dividend
5.1 Amount
- LPTX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
LEAP THERAPEUTICS INC / LPTX FAQ
Can you provide the ChartMill fundamental rating for LEAP THERAPEUTICS INC?
ChartMill assigns a fundamental rating of 2 / 10 to LPTX.
Can you provide the valuation status for LEAP THERAPEUTICS INC?
ChartMill assigns a valuation rating of 0 / 10 to LEAP THERAPEUTICS INC (LPTX). This can be considered as Overvalued.
What is the profitability of LPTX stock?
LEAP THERAPEUTICS INC (LPTX) has a profitability rating of 0 / 10.